Markt oder Branche auswählen:
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Icelandair Group hf.: Number of passengers increased by 14% in October | 279 | GlobeNewswire (Europe) | Icelandair carried a total of 464 thousand passengers in October, a 14% increase year-over-year. The growth was strong in the market to Iceland, where passenger numbers rose by 20% and in the market... ► Artikel lesen | |
| Do | Alvotech and Advanz Pharma Receive Marketing Authorisations for Gobivaz, a Biosimilar to Simponi (golimumab), from the MHRA | 125 | GlobeNewswire (Europe) | REYKJAVIK, ICELAND and LONDON, UK (November 06, 2025) - Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide... ► Artikel lesen |
| Aktien WKN | Akt. Kurs Vortag | +/- % | Zeit | ||
|---|---|---|---|---|---|
| ALVOTECH A3DK8U Frankfurt | 4,240 4,140 | +0,100 +2,42 % | 06.11. | ||
| ARION BANK HF SDR A2JNAX Frankfurt | 1,160 1,170 | -0,010 -0,85 % | 06.11. | ||
| JBT MAREL CORPORATION A0Q6F9 Tradegate | 120,000 123,00 | -2,00 -1,64 % | 06.11. | ||
| OCULIS HOLDING AG A3D8QG Frankfurt | 16,100 16,100 | 0,000 0,00 % | 06.11. |
Do
Icelandair carried a total of 464 thousand passengers in October, a 14% increase year-over-year. The growth was strong in the market to Iceland, where passenger numbers rose by 20% and in the market from Iceland, which grew by 31%. Of all passengers...
► Artikel lesen
► Artikel lesen
Aktien im Artikel:
So
REYKJAVIK, ICELAND (November 2, 2025) - Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that the U.S. Food and Drug Administration (FDA)...
► Artikel lesen
► Artikel lesen
Aktien im Artikel:
30.10.
ZUG, Switzerland, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) ("Oculis" or the "Company"), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in ophthalmology...
► Artikel lesen
► Artikel lesen
Aktien im Artikel:
Mi
At a board meeting on 5 November 2025, the Board of Directors and the CEO approved the interim consolidated financial statements of the Kvika banki hf. ("Kvika" or "the bank") for the third quarter and first nine months of 2025. Highlights of performance...
► Artikel lesen
► Artikel lesen
Aktien im Artikel:
30.10.
Íslandsbanki reported a net profit of ISK 6.9 billion in the third quarter of 2025, generating an annualised return on equity (ROE) of 12.2%
3Q25 RESULTS HIGHLIGHTSThird quarter 2025 (3Q25) financial highlightsNet profit amounted to ISK 6.9 billion...
► Artikel lesen
► Artikel lesen
Aktien im Artikel:
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .